Heimesaat Markus M, Mousavi Soraya, Shayya Nizar W, Bittroff-Leben Alexandra, Puschendorf Ines, Reifenberger Gernot, Bereswill Stefan
Gastrointestinal Microbiology Research Group, Institute of Microbiology, Infectious Diseases and Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Eur J Microbiol Immunol (Bp). 2025 Apr 14;15(2):125-136. doi: 10.1556/1886.2025.00015. Print 2025 Jun 30.
Besides its live-saving properties, antibiotic treatment affects the commensal microbiota facilitating colonization with potentially harmful microorganisms. Here we tested how commonly applied antibiotics induced gut microbiota changes and predisposed to intestinal carriage of multi-drug resistant Pseudomonas aeruginosa (MDR Psae) upon exposure. Therefore, mice received either vancomycin, ciprofloxacin, ampicillin plus sulbactam (A/S) or no antibiotics via the drinking water and were perorally challenged with a clinical MDR Psae isolate after antibiotic withdrawal. Whereas 100% of A/S and 55% of ciprofloxacin pretreated mice harbored Psae in their feces seven days post-challenge, intestinal Psae carriage rates were 20.0% and 26.3% in vancomycin pretreated and untreated mice, respectively. Microbiota analyses revealed that immediately before MDR Psae challenge, A/S pretreated mice displayed the lowest total bacterial, lactobacilli and Clostridium leptum fecal loads compared to other cohorts. Seven days following Psae exposure, however, higher numbers of apoptotic colonic epithelial cells were observed in A/S pretreated versus untreated mice that were accompanied by more enhanced innate and adaptive immune cell responses and nitric oxide secretion in colonic and ileal biopsies in the former versus the latter. In conclusion, distinct gut microbiota shifts following A/S pretreatment facilitate pronounced intestinal MDR Psae colonization and pro-inflammatory immune responses upon oral exposure.
除了其挽救生命的特性外,抗生素治疗还会影响共生微生物群,从而促进潜在有害微生物的定植。在此,我们测试了常用抗生素如何引起肠道微生物群变化,并在暴露后使肠道易于携带多重耐药铜绿假单胞菌(MDR Psae)。因此,小鼠通过饮用水接受万古霉素、环丙沙星、氨苄西林加舒巴坦(A/S)或不接受抗生素治疗,并在停用抗生素后经口用临床MDR Psae分离株进行攻击。攻击后7天,100%接受A/S治疗和55%接受环丙沙星治疗的小鼠粪便中携带Psae,而接受万古霉素治疗和未接受治疗的小鼠肠道Psae携带率分别为20.0%和26.3%。微生物群分析显示,在MDR Psae攻击前,与其他组相比,接受A/S治疗的小鼠粪便中总细菌、乳酸杆菌和纤细梭菌的负荷最低。然而,在暴露于Psae 7天后,与未接受治疗的小鼠相比,接受A/S治疗的小鼠结肠上皮细胞凋亡数量更多,同时前者结肠和回肠活检中的固有免疫和适应性免疫细胞反应以及一氧化氮分泌比后者更强。总之,A/S预处理后不同的肠道微生物群变化促进了口服暴露后明显的肠道MDR Psae定植和促炎免疫反应。